SCHEMBL1079558

SCHEMBL1079558

CCCC(C)c1cccs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
LMNA P02545 2/20 0.35
TP53 P04637 2/20 0.35
POLB P06746 1/20 0.35
THRB P10828 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
KEAP1 Q14145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175346 0.88 GLA (0.40) ALOX5MAPTLMNATP53POLB
SCHEMBL22025440 0.86 ALOX5 (0.37) ALOX5MAPTOPRM1LMNATP53
SCHEMBL4948031 0.85 HDAC1 (0.38) ALOX5MAPTOPRM1LMNANPSR1
SCHEMBL12311962 0.83
SCHEMBL94688 0.83
SCHEMBL12808832 0.82 ALOX5 (0.39) ALOX5MAPTOPRM1LMNATP53
SCHEMBL5481200 0.82 ALOX5 (0.42) ALOX5OPRM1LMNATP53POLB
SCHEMBL6709750 0.82 ALOX5 (0.39) ALOX5MAPTOPRM1LMNATP53
SCHEMBL3925265 0.82 ALOX5 (0.39) ALOX5MAPTOPRM1LMNATP53
SCHEMBL27261957 0.82 ALOX5 (0.39) ALOX5MAPTOPRM1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250268292-A1 PRODUCTION OF PHOSPHOLIPIDS IN MICROBES AND USES THEREOF Nourish Ingredients Pty Ltd (AU) 2025-08-28 US claimed
EP-4583722-A1 COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH MEAT-LIKE AROMAS Nourish Ingredients Pty Ltd (AU) 2025-07-16 EP claimed
EP-4583721-A1 COMPOSITIONS AND METHODS FOR PRODUCING MEAT-LIKE AROMAS Nourish Ingredients Pty Ltd (AU) 2025-07-16 EP claimed
EP-4583719-A1 COMPOSITIONS AND METHODS FOR PRODUCING AROMAS Nourish Ingredients Pty Ltd (AU) 2025-07-16 EP claimed
EP-4583720-A1 COMPOSITIONS AND METHODS FOR PRODUCING MEAT-LIKE AROMAS Nourish Ingredients Pty Ltd (AU) 2025-07-16 EP claimed
US-20240407418-A1 COMPOSITIONS AND METHODS FOR PRODUCING AROMAS Nourish Ingredients Pty Ltd (AU) 2024-12-12 US claimed
EP-4418875-A1 COMPOSITIONS AND METHODS FOR PRODUCING AROMAS Nourish Ingredients Pty Ltd (AU) 2024-08-28 EP claimed
WO-2024050591-A1 COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH MEAT-LIKE AROMAS Nourish Ingredients Pty Ltd (AU) 2024-03-14 WO claimed
WO-2024050588-A1 COMPOSITIONS AND METHODS FOR PRODUCING AROMAS Nourish Ingredients Pty Ltd (AU) 2024-03-14 WO claimed
WO-2024050590-A1 COMPOSITIONS AND METHODS FOR PRODUCING MEAT-LIKE AROMAS Nourish Ingredients Pty Ltd (AU) 2024-03-14 WO claimed
EP-1718342-A1 TECHNETIUM-AND RHENIUM-BIS(HETEROARYL) COMPLEXES, AND METHODS OF USE THEREOF Molecular Insight Pharmaceuticals, Inc. (US) 2006-11-08 EP claimed
EP-1713515-A1 TECHNETIUM- AND RHENIUM-BIS(HETEROARYL) COMPLEXES, AND METHODS OF USE THEREOF Molecular Insight Pharmaceuticals, Inc. (US) 2006-10-25 EP claimed
EP-1482985-A4 TECHNETIUM-DIPYRIDINE COMPLEXES, AND METHODS OF USE THEREOF MOLECULAR INSIGHT PHARM INC (US) 2006-06-28 EP claimed
US-20060093552-A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) 2006-05-04 US claimed
US-20060034758-A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) 2006-02-16 US claimed
WO-2005079865-A1 TECHNETIUM- AND RHENIUM-BIS(HETEROARYL) COMPLEXES, AND METHODS OF USE THEREOF MOLECULAR INSIGHT PHARMACEUTICALS (US) 2005-09-01 WO claimed
WO-2005079866-A1 TECHNETIUM-AND RHENIUM-BIS(HETEROARYL) COMPLEXES, AND METHODS OF USE THEREOF MOLECULAR INSIGHT PHARMACEUTICALS (US) 2005-09-01 WO claimed
EP-1482985-A2 TECHNETIUM-DIPYRIDINE COMPLEXES, AND METHODS OF USE THEREOF Biostream, Inc. (US) 2004-12-08 EP claimed
US-20030235843-A1 Technetium-depyridine complexes, and methods of use thereof CITIZENS BANK, N.A. 2003-12-25 US claimed
WO-2003077727-A2 TECHNETIUM-DIPYRIDINE COMPLEXES, AND METHODS OF USE THEREOF BIOSTREAM, INC. (US) 2003-09-25 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060093552-A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof SLC7A5, QPCT, RAB35 ALOX5 4148/4885TAS1R3 2694/4885TAS1R1 2754/4885
US-20030235843-A1 Technetium-depyridine complexes, and methods of use thereof SLC7A5, DNPEP, SLC7A1 ALOX5 4029/4885TAS1R3 3479/4885TAS1R1 3382/4885
US-20060034758-A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof SLC7A5, RAB35, AADAT ALOX5 4119/4885TAS1R3 3300/4885TAS1R1 3622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.